Cross-presentation of exogenous antigens on MHC I molecules
- PMID: 31927332
- PMCID: PMC7343603
- DOI: 10.1016/j.coi.2019.12.005
Cross-presentation of exogenous antigens on MHC I molecules
Abstract
In order to get recognized by CD8 T cells, most cells present peptides from endogenously expressed self or foreign proteins on MHC class I molecules. However, specialized antigen-presenting cells, such as DCs and macrophages, can present exogenous antigen on MHC-I in a process called cross-presentation. This pathway plays key roles in antimicrobial and antitumor immunity, and also immune tolerance. Recent advances have broadened our understanding of the underlying mechanisms of cross-presentation. Here, we review some of these recent advances, including the distinct pathways that result in the cross-priming of CD8 T cells and the source of the class I molecules presenting exogenous peptides.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Conflicts of interest
The authors have no conflicts of interest to declare.
Figures


References
-
- Huang AY, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H: Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 1994, 264:961–965. - PubMed
-
- Sigal LJ, Crotty S, Andino R, Rock KL: Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 1999, 398:77–80. - PubMed
-
- Luckashenak N, Schroeder S, Endt K, Schmidt D, Mahnke K, Bachmann MF, Marconi P, Deeg CA, Brocker T: Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8+ T cell tolerance in vivo. Immunity 2008, 28:521–532. - PubMed
-
- Rock KL, Gamble S, Rothstein L: Presentation of exogenous antigen with class I major histocompatibility complex molecules. Science 1990, 249:918–921. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials